Cargando…
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
Dexmedetomidine is an α2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe t...
Autores principales: | Max, Bryan A., Mason, Keira P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946583/ https://www.ncbi.nlm.nih.gov/pubmed/20885920 http://dx.doi.org/10.1155/2010/825079 |
Ejemplares similares
-
Heart rate variability during infusion of dexmedetomidine
por: Imabayashi, T, et al.
Publicado: (2011) -
Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery
por: Aikaterini, Amaniti, et al.
Publicado: (2018) -
Dexmedetomidine: What’s New for Pediatrics? A Narrative Review
por: Mahmoud, Mohamed, et al.
Publicado: (2020) -
Dexmedetomidine Infusion to Facilitate Opioid Detoxification and Withdrawal in a Patient with Chronic Opioid Abuse
por: Upadhyay, Surjya Prasad, et al.
Publicado: (2011) -
Epidural dexmedetomidine infusion in a patient with chronic opioid use and intractable pain following abdominoperineal resection
por: Silvaggio, Mathew P, et al.
Publicado: (2020)